Bank of America’s POINT Biopharma Global Inc. Common Stock PNT Stock Holding History

Bank of America’s Portfolio PNT Stock Details PNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-307,222	Closed	-$2.05M	–	8317
2023 Q3	$2.05M	Buy	307,222 +149,604	+95%	+$1.24M	﹤0.01%	4224
2023 Q2	$1.43M	Sell	157,618 -231,646	-60%	-$2.04M	﹤0.01%	4505
2023 Q1	$2.83M	Sell	389,264 -26,513	-6%	-$197K	﹤0.01%	4054
2022 Q4	$3.03M	Buy	415,777 +235,415	+131%	+$1.75M	﹤0.01%	3878
2022 Q3	$1.39M	Buy	180,362 +91,529	+103%	+$777K	﹤0.01%	4620
2022 Q2	$605K	Sell	88,833 -22,825	-20%	-$175K	﹤0.01%	5286
2022 Q1	$889K	Buy	111,658 +32,958	+42%	+$209K	﹤0.01%	5379
2021 Q4	$441K	Buy	78,700 +73,085	+1,302%	+$548K	﹤0.01%	5987
2021 Q3	$43K	Buy	+5,615	New	+$51.2K	﹤0.01%	7123

Other funds holding PNT

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Bank of America's PNT Position: Q4 2023 in Review

Bank of America sold out of POINT Biopharma Global Inc. Common Stock (PNT) in Q4 2023, closing a stake of 307,222 shares — an estimated $2.05M sold.

Bank of America first reported a position in PNT in Q3 2021 and held it in 9 quarters. The position peaked at $3.03M in Q4 2022. 1 fund tracked by Wall St. Rank holds PNT as of Q4 2023.

Bank of America reported no remaining POINT Biopharma Global Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Bank of America sold 307,222 POINT Biopharma Global Inc. Common Stock shares in Q4 2023, an estimated $2.05M.
Bank of America first reported a position in POINT Biopharma Global Inc. Common Stock in Q3 2021 and held it in 9 quarters.
Bank of America's POINT Biopharma Global Inc. Common Stock position peaked at $3.03M in Q4 2022.
1 fund tracked by Wall St. Rank held POINT Biopharma Global Inc. Common Stock as of Q4 2023.

Based on Bank of America's 13F filing for Q4 2023, filed 14 Feb 2024.